JP2023525345A5 - - Google Patents

Info

Publication number
JP2023525345A5
JP2023525345A5 JP2022568961A JP2022568961A JP2023525345A5 JP 2023525345 A5 JP2023525345 A5 JP 2023525345A5 JP 2022568961 A JP2022568961 A JP 2022568961A JP 2022568961 A JP2022568961 A JP 2022568961A JP 2023525345 A5 JP2023525345 A5 JP 2023525345A5
Authority
JP
Japan
Prior art keywords
lymphocytes
hematopoietic tissue
tissue sample
interleukin
culturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022568961A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023525345A (ja
Filing date
Publication date
Priority claimed from GBGB2006989.4A external-priority patent/GB202006989D0/en
Application filed filed Critical
Publication of JP2023525345A publication Critical patent/JP2023525345A/ja
Publication of JP2023525345A5 publication Critical patent/JP2023525345A5/ja
Pending legal-status Critical Current

Links

JP2022568961A 2020-05-12 2021-05-12 ガンマデルタt細胞を単離する方法 Pending JP2023525345A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2006989.4 2020-05-12
GBGB2006989.4A GB202006989D0 (en) 2020-05-12 2020-05-12 Methods for isolating gamma delta t cells
PCT/GB2021/051144 WO2021229226A1 (en) 2020-05-12 2021-05-12 Methods for isolating gamma delta t cells

Publications (2)

Publication Number Publication Date
JP2023525345A JP2023525345A (ja) 2023-06-15
JP2023525345A5 true JP2023525345A5 (cg-RX-API-DMAC7.html) 2024-05-23

Family

ID=71134832

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022568961A Pending JP2023525345A (ja) 2020-05-12 2021-05-12 ガンマデルタt細胞を単離する方法

Country Status (13)

Country Link
US (1) US20230227777A1 (cg-RX-API-DMAC7.html)
EP (1) EP4150055A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023525345A (cg-RX-API-DMAC7.html)
KR (1) KR20230010209A (cg-RX-API-DMAC7.html)
CN (2) CN121294340A (cg-RX-API-DMAC7.html)
AU (1) AU2021271222A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022022939A2 (cg-RX-API-DMAC7.html)
CA (1) CA3183145A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022017768A2 (cg-RX-API-DMAC7.html)
GB (1) GB202006989D0 (cg-RX-API-DMAC7.html)
IL (1) IL298000A (cg-RX-API-DMAC7.html)
MX (1) MX2022014111A (cg-RX-API-DMAC7.html)
WO (1) WO2021229226A1 (cg-RX-API-DMAC7.html)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028176A (en) 1996-07-19 2000-02-22 Bayer Corporation High-affinity interleukin-4 muteins
CN101120083B (zh) 2003-10-08 2013-03-27 威尔森沃尔夫制造公司 利用透气性材料进行细胞培养的方法及装置
EP1777294A1 (en) 2005-10-20 2007-04-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins
US20070122413A1 (en) 2005-11-28 2007-05-31 Sivakumar Pallavur V Il-21 antagonists
US8617531B2 (en) 2006-12-14 2013-12-31 Bolder Biotechnology, Inc. Methods of making proteins and peptides containing a single free cysteine
WO2012088446A1 (en) 2010-12-22 2012-06-28 Board Of Trustees Of The Leland Stanford Junior University Superagonists and antagonists of interleukin-2
UA123821C2 (uk) 2014-06-11 2021-06-09 Полібіосепт Гмбх Композиція для експансії лімфоцитів in vitro
KR20240063197A (ko) * 2015-06-09 2024-05-09 감마델타 테라퓨틱스 엘티디 Tcr 감마 델타 양성 t 세포의 생산 방법
JP6799895B2 (ja) * 2015-06-09 2020-12-16 リンファクト−リンフォサイト アクティベイション テクノロジーズ エス.エー. TCRγδ+T細胞の生産方法
CN108473958A (zh) * 2015-10-30 2018-08-31 癌症研究技术有限公司 非造血组织驻留γδT细胞的扩增及这些细胞的用途
CN118421557A (zh) * 2016-05-12 2024-08-02 阿迪塞特治疗公司 选择性扩增γδT细胞群的方法及其组合物
JOP20190224A1 (ar) * 2017-03-29 2019-09-26 Iovance Biotherapeutics Inc عمليات من أجل إنتاج الخلايا اللمفاوية المرتشحة للأورام واستخداماتها في العلاج المناعي
GB201707048D0 (en) * 2017-05-03 2017-06-14 King S College London Expansion of gamma delta cells, compositions, and methods of use thereof
JP7557367B2 (ja) * 2017-11-17 2024-09-27 アイオバンス バイオセラピューティクス,インコーポレイテッド 細針吸引及び小生検からのtil拡大培養
GB202002581D0 (en) * 2020-02-24 2020-04-08 Gammadelta Therapeutics Ltd Novel antibodies

Similar Documents

Publication Publication Date Title
MacDonald et al. Methods to manufacture regulatory T cells for cell therapy
JP2022506836A5 (cg-RX-API-DMAC7.html)
JP5101559B2 (ja) invitroにおけるCD14陽性単球からの樹状細胞の産出
Ichikawa et al. Hepatic stellate cells function as regulatory bystanders
CN112458053B (zh) 一种基于滋养层细胞的脐血Treg细胞体外扩增方法及应用
CA2122141C (en) Methods for selectively expanding stem cells
KR101732532B1 (ko) 단구 또는 nk 세포를 입수하는 방법
EP3303569A1 (en) Semi-static cell culture
CN107164323A (zh) 一种获得具高杀伤肿瘤细胞能力的淋巴细胞亚群的方法
CN112725267A (zh) 一种pbmc和msc共培养的方法及其应用
CN110938595B (zh) 一种高效体外培养脐血cik细胞的培养基及培养方法
CN112680415A (zh) 一种nk培养基及其扩增培养方法
CN115094034B (zh) 一种人nkt细胞系及其应用
Selvaraj et al. Influence of HLA-DR2 phenotype on humoral immunity & lymphocyte response to Mycobacterium tuberculosis culture filtrate antigens in pulmonary tuberculosis
CN108251370A (zh) 非细胞来源的多肽致敏的dc-cik细胞、其构建方法及应用
Delles et al. A simple method for the purification of human peripheral blood antigen presenting cells (dendritic cells, monocytes/macrophages, and B lymphocytes)
CN108949686B (zh) 一种在低氧环境中从胎盘中获取造血干细胞的方法
CN1244691C (zh) 自体胸水上清培养til细胞的方法
CN113817683A (zh) 一种肺癌类器官的培养基及其应用
CN113502268A (zh) 一种树突状细胞的制备方法
RU2796356C9 (ru) КЛЕТОЧНАЯ ЛИНИЯ АЛЬВЕОЛЯРНОЙ САРКОМЫ ЧЕЛОВЕКА 9927 AlS SIO
CN119410582B (zh) 干细胞样记忆性t淋巴细胞的培养基和培养方法
CN112858688A (zh) Slamf7表达的cd4+t细胞在制备结核病诊断或治疗试剂中的应用
CN117736988B (zh) 用于诱导Tscm细胞的培养基、培养方法及其应用
CN119082023A (zh) 冻存脐带血造血干细胞来源的nk细胞的制备方法